Segui
Javid Sadri Nahand
Titolo
Citata da
Citata da
Anno
Breast cancer diagnosis: Imaging techniques and biochemical markers
SH Jafari, Z Saadatpour, A Salmaninejad, F Momeni, M Mokhtari, ...
Journal of cellular physiology 233 (7), 5200-5213, 2018
4882018
MicroRNA: A novel target of curcumin in cancer therapy
H Mirzaei, A Masoudifar, A Sahebkar, N Zare, J Sadri Nahand, B Rashidi, ...
Journal of cellular physiology 233 (4), 3004-3015, 2018
2562018
Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: a review
J Sadri Nahand, M Moghoofei, A Salmaninejad, Z Bahmanpour, ...
International journal of cancer 146 (2), 305-320, 2020
2152020
microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer
JS Nahand, S Taghizadeh‐boroujeni, M Karimzadeh, S Borran, ...
Journal of cellular physiology 234 (10), 17064-17099, 2019
1832019
MicroRNAs and exosomes in depression: potential diagnostic biomarkers
J Tavakolizadeh, K Roshanaei, A Salmaninejad, R Yari, JS Nahand, ...
Journal of Cellular Biochemistry 119 (5), 3783-3797, 2018
1632018
Epi-drugs and Epi-miRs: moving beyond current cancer therapies
R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ...
Current cancer drug targets 16 (9), 773-788, 2016
1382016
Therapeutic application of multipotent stem cells
H Mirzaei, A Sahebkar, LS Sichani, A Moridikia, S Nazari, J Sadri Nahand, ...
Journal of cellular physiology 233 (4), 2815-2823, 2018
1372018
MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers
K Golabchi, R Soleimani‐Jelodar, N Aghadoost, F Momeni, A Moridikia, ...
Journal of cellular physiology 233 (4), 3016-3023, 2018
1272018
Chitosan-based nanoparticles against viral infections
H Boroumand, F Badie, S Mazaheri, ZS Seyedi, JS Nahand, M Nejati, ...
Frontiers in Cellular and Infection Microbiology 11, 643953, 2021
1242021
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC
T Donyavi, F Bokharaei-Salim, HB Baghi, K Khanaliha, MA Janat-Makan, ...
International immunopharmacology 97, 107641, 2021
1022021
Boron neutron capture therapy: Moving toward targeted cancer therapy
HR Mirzaei, A Sahebkar, R Salehi, JS Nahand, E Karimi, MR Jaafari, ...
Journal of cancer research and therapeutics 12 (2), 520-525, 2016
1022016
Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
SMR Hashemian, A Sheida, M Taghizadieh, MY Memar, MR Hamblin, ...
Biomedicine & Pharmacotherapy 162, 114367, 2023
1012023
Influenza vaccine: Where are we and where do we go?
M Keshavarz, H Mirzaei, M Salemi, F Momeni, MJ Mousavi, ...
Reviews in medical virology 29 (1), e2014, 2019
942019
Genetic and epigenetic contribution to astrocytic gliomas pathogenesis
P Khani, F Nasri, F Khani Chamani, F Saeidi, J Sadri Nahand, ...
Journal of neurochemistry 148 (2), 188-203, 2019
932019
Exosomal microRNAs: novel players in cervical cancer
JS Nahand, NR Vandchali, H Darabi, M Doroudian, HR Banafshe, ...
Epigenomics 12 (18), 1651-1660, 2020
922020
MicroRNA let-7 and viral infections: focus on mechanisms of action
A Letafati, S Najafi, M Mottahedi, M Karimzadeh, A Shahini, S Garousi, ...
Cellular & Molecular Biology Letters 27 (1), 14, 2022
872022
MicroRNAs and exosomes: key players in HIV pathogenesis
J Sadri Nahand, F Bokharaei‐Salim, M Karimzadeh, M Moghoofei, ...
HIV medicine 21 (4), 246-278, 2020
852020
Exosomal miRNAs: novel players in viral infection
JS Nahand, M Mahjoubin-Tehran, M Moghoofei, MH Pourhanifeh, ...
Epigenomics 12 (4), 353-370, 2020
762020
Circular RNAs: new epigenetic signatures in viral infections
JS Nahand, S Jamshidi, MR Hamblin, M Mahjoubin-Tehran, M Vosough, ...
Frontiers in microbiology 11, 1853, 2020
722020
Cell death pathways and viruses: role of microRNAs
JS Nahand, L Shojaie, SA Akhlagh, MS Ebrahimi, HR Mirzaei, HB Baghi, ...
Molecular Therapy-Nucleic Acids 24, 487-511, 2021
682021
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20